Peter Attia· MD
if you look at its monotherapy trials it's like a zettabyte you're going to get anywhere from a 10 to 18 percent lowering of ldl cholesterol by itself a tad less april b 10 to 12 percent
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
if you look at its monotherapy trials it's like a zettabyte you're going to get anywhere from a 10 to 18 percent lowering of ldl cholesterol by itself a tad less april b 10 to 12 percent
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
of acronym for a lowd do Statin and you combine it with a zmi bidic acid or p p sk9 inhibitor you've got a uh a military machine that can destroy APO B so that's should be the thought processes about attacking April B nowadays